{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-22-019616","form_type":"8-K","ticker":"ZEOX","cik":"0001557376","company_name":"Zeo ScientifiX, Inc.","filed_at":"2022-12-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.138910+00:00","generated_at":"2026-06-21T10:53:58.174866+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Organicell CEO Matthew Sinnreich resigns; CFO Ian Bothwell appointed interim CEO","bullets":["Matthew Sinnreich resigned as Acting CEO, President, and Board member effective November 29, 2022.","CFO Ian Bothwell appointed Interim CEO; board begins search for permanent CEO.","Board aims to complete CEO search within the next 90 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-22-019616","json":"https://secwatch.observer/filing/0001829126-22-019616.json","markdown":"https://secwatch.observer/filing/0001829126-22-019616.md","text":"https://secwatch.observer/filing/0001829126-22-019616.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557376/000182912622019616/0001829126-22-019616-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557376/000182912622019616/organicellregn_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T10:53:58.174866+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2402e3c504","claim":"Ian Bothwell was appointed as Interim Chief Executive Officer at Zeo ScientifiX, Inc..","evidence_excerpt":"The Board also agreed to appoint Mr. Ian Bothwell, the Company’s Chief Financial Officer to serve as the Company’s Interim Chief Executive Officer while the Board commences its process to identify suitable candidates to fill the Chief Executive Officer position.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912622019616/0001829126-22-019616-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"59176246c1","claim":"Matthew Sinnreich resigned as Acting Chief Executive Officer and President at Zeo ScientifiX, Inc..","evidence_excerpt":"On November 29, 2022, Organicell’s Board of Directors (“Board”) agreed to accept the resignation of Mr. Matthew Sinnreich, who was previously serving as the Acting Chief Executive Officer and President of the Company and as a member of the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912622019616/0001829126-22-019616-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Acting Chief Executive Officer and President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}